Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Dr Paul Hendrick Sugarbaker has been at the Washington Cancer Institute since 1989 as Director for the Program in Peritoneal Surface Malignancy. His interests are in gastrointestinal cancer, gynecologic malignancy and mesothelioma. Dr Sugarbaker is a strong critic of surgical tradition; he believes that major changes in the technology of cancer resection are necessary. His theme, ‘It’s what the surgeon doesn’t see that kills the patient’, summarizes the concepts behind many of his publications in the peer-reviewed medical literature. In the opinion of Dr Sugarbaker, perioperative intravenous and intraperitoneal chemotherapy are an essential planned part of many cancer interventions.
The Chief Medical Officer has confirmed that attendance at the Surgical Grand Rounds can count toward internal CPD, with 1 point awarded per hour. Please note that in-person attendance is required, and you will need to sign the attendance register.
Please email Louise King (louise.king@nds.ox.ac.uk) if you would like to attend online.
